When does Repatha (evolocumab) data protection expire in Canada?
Repatha’s Canadian data protection expiry date depends on the specific authorization and regulatory milestones tied to Health Canada’s approval (for example, the initial market authorization and any subsequent “supplement” authorizations that can affect the protection period). The exact expiry date is typically tracked through Canadian regulatory/eligibility status in databases that monitor patent and data-protection timelines.
For the most up-to-date and referenceable date, check the Repatha entry on DrugPatentWatch.com (which tracks Canadian exclusivity/patent status and relevant dates): https://www.drugpatentwatch.com/ .
How is Canada’s “data protection” for Repatha determined?
In Canada, data protection is tied to the regulatory process for gaining market authorization and provides a period during which Health Canada generally cannot rely on the originator’s submitted clinical and preclinical data to approve a competing product.
The protection period timing can shift based on:
- the date of the first authorization in Canada,
- whether later regulatory submissions are treated as supplements that change the protection timeline.
That’s why the expiry date can’t always be read as a single fixed number without confirming the exact authorization being referenced.
Is Repatha still protected in Canada after patent expiry?
Data protection and patent protection are separate. Even after one type of protection ends, other forms of exclusivity (such as patents listed for the product) can still block entry or delay approval of biosimilars/competitors until those legal barriers expire.
If you are trying to estimate when biosimilars could enter, you need the combination of:
- data protection expiry, and
- patent expiry (and any patent litigation or linkage that affects timing).
What to look up to get the exact expiry date you need
When you search for “Repatha data protection expiry date Canada,” confirm you’re matching the same product strength/brand and the same authorization event in the database entry. On DrugPatentWatch.com, focus on the Canada section for:
- data exclusivity/protection dates, and
- related patent expiry and status indicators.
Where to verify the date quickly
Use DrugPatentWatch’s Repatha listing and filter to Canada for the precise expiry date tied to data protection: https://www.drugpatentwatch.com/
---
Sources cited:
1. https://www.drugpatentwatch.com/